Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 24 | 2022 | 67 | 6.610 |
Why?
|
| Tourette Syndrome | 9 | 2021 | 15 | 3.450 |
Why?
|
| Parkinson Disease | 6 | 2020 | 131 | 2.000 |
Why?
|
| Essential Tremor | 6 | 2020 | 19 | 1.780 |
Why?
|
| Globus Pallidus | 6 | 2020 | 26 | 1.040 |
Why?
|
| Subthalamic Nucleus | 4 | 2020 | 15 | 0.930 |
Why?
|
| Tics | 2 | 2021 | 7 | 0.920 |
Why?
|
| Fornix, Brain | 3 | 2022 | 10 | 0.860 |
Why?
|
| Spinal Cord Compression | 1 | 2023 | 30 | 0.810 |
Why?
|
| Dyskinesias | 2 | 2020 | 9 | 0.800 |
Why?
|
| Meningeal Neoplasms | 1 | 2023 | 59 | 0.790 |
Why?
|
| Meningioma | 1 | 2023 | 60 | 0.790 |
Why?
|
| Spinal Cord Diseases | 1 | 2023 | 39 | 0.790 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 71 | 0.780 |
Why?
|
| Patient Selection | 3 | 2021 | 490 | 0.760 |
Why?
|
| Memory | 2 | 2021 | 120 | 0.740 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 721 | 0.730 |
Why?
|
| Movement Disorders | 1 | 2021 | 24 | 0.700 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 76 | 0.630 |
Why?
|
| Electrodes, Implanted | 2 | 2021 | 38 | 0.590 |
Why?
|
| Biomedical Research | 1 | 2021 | 268 | 0.570 |
Why?
|
| Electric Impedance | 1 | 2017 | 36 | 0.550 |
Why?
|
| Anxiety | 1 | 2020 | 425 | 0.520 |
Why?
|
| Hair Dyes | 1 | 2014 | 5 | 0.440 |
Why?
|
| Dystonia | 3 | 2020 | 13 | 0.440 |
Why?
|
| Dementia | 1 | 2018 | 260 | 0.440 |
Why?
|
| Humans | 34 | 2023 | 63445 | 0.440 |
Why?
|
| Lead Poisoning | 1 | 2014 | 10 | 0.440 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 28 | 0.430 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 1553 | 0.390 |
Why?
|
| Tic Disorders | 2 | 2021 | 5 | 0.340 |
Why?
|
| Ventral Thalamic Nuclei | 2 | 2020 | 7 | 0.320 |
Why?
|
| Male | 16 | 2021 | 29888 | 0.300 |
Why?
|
| Brain Mapping | 3 | 2023 | 232 | 0.250 |
Why?
|
| Thalamus | 3 | 2022 | 73 | 0.240 |
Why?
|
| Registries | 2 | 2019 | 888 | 0.220 |
Why?
|
| Child | 4 | 2021 | 4526 | 0.210 |
Why?
|
| Female | 11 | 2023 | 32877 | 0.210 |
Why?
|
| Middle Aged | 11 | 2021 | 17611 | 0.210 |
Why?
|
| Treatment Outcome | 6 | 2020 | 5680 | 0.210 |
Why?
|
| Young Adult | 4 | 2021 | 4694 | 0.200 |
Why?
|
| Autonomic Nervous System | 1 | 2021 | 36 | 0.180 |
Why?
|
| Acceleration | 1 | 2021 | 35 | 0.180 |
Why?
|
| Electromyography | 1 | 2021 | 96 | 0.180 |
Why?
|
| Adolescent | 3 | 2021 | 6245 | 0.180 |
Why?
|
| Hypothalamus | 1 | 2021 | 132 | 0.180 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 2 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 69 | 0.170 |
Why?
|
| Affect | 1 | 2021 | 125 | 0.170 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2020 | 3 | 0.170 |
Why?
|
| Dystonic Disorders | 1 | 2020 | 8 | 0.170 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 77 | 0.170 |
Why?
|
| Aged | 7 | 2021 | 14445 | 0.170 |
Why?
|
| Adult | 7 | 2021 | 16823 | 0.170 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 4 | 0.160 |
Why?
|
| Tremor | 1 | 2020 | 24 | 0.160 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 16 | 0.160 |
Why?
|
| Brain | 4 | 2023 | 1552 | 0.160 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2020 | 19 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 658 | 0.160 |
Why?
|
| Corpus Callosum | 1 | 2019 | 42 | 0.150 |
Why?
|
| Comorbidity | 2 | 2021 | 1120 | 0.150 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2019 | 17 | 0.150 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2019 | 13 | 0.150 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2019 | 7 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2019 | 873 | 0.150 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 36 | 0.150 |
Why?
|
| Basal Nucleus of Meynert | 1 | 2018 | 2 | 0.140 |
Why?
|
| Cognition | 1 | 2021 | 484 | 0.140 |
Why?
|
| Equipment Failure | 1 | 2017 | 67 | 0.140 |
Why?
|
| Thalamic Nuclei | 1 | 2017 | 24 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2019 | 167 | 0.130 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 22 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 2016 | 77 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 978 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2016 | 105 | 0.120 |
Why?
|
| Electric Injuries | 1 | 2014 | 3 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6657 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 18 | 0.110 |
Why?
|
| Edema | 1 | 2014 | 43 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2458 | 0.110 |
Why?
|
| Lead | 1 | 2014 | 43 | 0.110 |
Why?
|
| Quality of Life | 1 | 2020 | 1228 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 2172 | 0.050 |
Why?
|
| Tachycardia | 1 | 2021 | 29 | 0.050 |
Why?
|
| Body Temperature | 1 | 2021 | 45 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 284 | 0.050 |
Why?
|
| Electrodes | 1 | 2021 | 36 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 53 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2020 | 9 | 0.040 |
Why?
|
| Atrophy | 1 | 2020 | 83 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 293 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 177 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 772 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 153 | 0.040 |
Why?
|
| Software | 1 | 2021 | 389 | 0.040 |
Why?
|
| Gait | 1 | 2019 | 119 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 144 | 0.030 |
Why?
|
| International Cooperation | 1 | 2018 | 90 | 0.030 |
Why?
|
| Biophysics | 1 | 2017 | 42 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2016 | 53 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 69 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 712 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2016 | 34 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2014 | 35 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3293 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 75 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1008 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 3768 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2570 | 0.020 |
Why?
|